Bryan McVerry
Vice Chair of Veteran Affairs · UPMC Medical Education
Credentials: · ·
History
- Present
- 2000–2001
- 1988–1992
Research
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 1,514 citations
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 780 citations
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
New England Journal of Medicine · 2021 · 743 citations
78 papers · 45 as a fellow
- AM
58 papers
52 papers · 4 as a fellow
47 papers
24 papers · 4 as a fellow
23 papers
- CS
18 papers
- DH
17 papers
Grants
- 2014–2026
Immunosuppression in Acute Lung Injury
National Heart, Lung, and Blood Institute · P01
Project lead · $1.5M · Ohio State University
- 2009–2018
Sepsis-Associated Immune Suppression and F-Box Proteins
National Heart, Lung, and Blood Institute · R01
PI · $1.2M · Ohio State University
- 2007–2012
Sphingosine 1-Phosphate and the Pulmonary Vasculature: Implications for ALI
National Heart, Lung, and Blood Institute · K08
Contact PI · $624.6K · University of Pittsburgh at Pittsburgh
- 2004–2005
The Role of Sphingosine-1-Phosphate in Acute Lung Injury
National Heart, Lung, and Blood Institute · F32
Contact PI · $52.3K · Johns Hopkins University
Clinical trials
- 2024–2028
Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)
Site PI · Recruiting · Phase 2
BioAegis Therapeutics Inc.